Impact of ABO-Incompatible Listing on Wait-List Outcomes Among Infants Listed for Heart Transplantation in the United States A Propensity Analysis

被引:51
作者
Almond, Christopher S. [1 ,3 ,4 ]
Gauvreau, Kimberlee [1 ,6 ]
Thiagarajan, Ravi R. [1 ,4 ]
Piercey, Gary E. [1 ]
Blume, Elizabeth D. [1 ,3 ,4 ]
Smoot, Leslie B. [1 ,3 ,4 ]
Fynn-Thompson, Francis [2 ,3 ,5 ]
Singh, Tajinder P. [1 ,3 ,4 ]
机构
[1] Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA
[2] Childrens Hosp, Dept Cardiac Surg, Boston, MA 02115 USA
[3] Childrens Hosp, Pediat Transplant Ctr, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA
[5] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA
[6] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA
关键词
heart defects; congenital; heart failure; immunology; pediatrics; transplantation; CHILDREN; MORTALITY;
D O I
10.1161/CIRCULATIONAHA.109.885756
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-The purported advantage of ABO-incompatible (ABO-I) listing is to reduce wait times and wait-list mortality among infants awaiting heart transplantation. We sought to describe recent trends in ABO-I listing for US infants and to determine the impact of ABO-I listing on wait times and wait-list mortality. Methods and Results-In this multicenter retrospective cohort study using Organ Procurement and Transplant Network data, infants <12 months of age listed for heart transplantation between 1999 and 2008 (n = 1331) were analyzed. Infants listed for an ABO-I transplant were compared with a propensity score-matched cohort listed for an ABO-compatible transplant through the use of a Cox shared-frailty model. The primary end point was time to heart transplantation. The percentage of eligible infants listed for an ABO-I heart increased from 0% before 2002 to 53% in 2007 (P < 0.001 for trend). Compared with infants listed exclusively for an ABO-compatible heart, infants with a primary ABO-I listing strategy (n = 235) were more likely to be listed 1A, to have congenital heart disease and renal failure, and to require extracorporeal membrane oxygenation. For the propensity score-matched groups (n = 197 matched pairs), there was no difference in wait-list mortality; however, infants with blood type O assigned an ABO-I listing strategy were more likely to undergo heart transplantation by 30 days (31% versus 16%; P = 0.007) with a less pronounced effect for infants with other blood types. Conclusions-The proportion of US infants listed for an ABO-I heart transplantation has risen dramatically in recent years but still appears to be preferentially used for sicker infant candidates. The ABO-I listing strategy is associated with a higher likelihood of transplantation within 30 days for infants with blood group O and may benefit a broader range of transplantation candidates. (Circulation. 2010;121:1926-1933.)
引用
收藏
页码:1926 / 1933
页数:8
相关论文
共 21 条
[1]   Waiting List Mortality Among Children Listed for Heart Transplantation in the United States [J].
Almond, Christopher S. D. ;
Thiagarajan, Ravi R. ;
Piercey, Gary E. ;
Gauvreau, Kimberlee ;
Blume, Elizabeth D. ;
Bastardi, Heather J. ;
Fynn-Thompson, Francis ;
Singh, T. P. .
CIRCULATION, 2009, 119 (05) :717-727
[2]  
D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO
[3]  
2-B
[4]   Blood type incompatible cardiac transplantation in young infants [J].
Daebritz, Sabine H. ;
Schmoeckel, Michael ;
Mair, Helmut ;
Kozlik-Feldmann, Rainer ;
Wittmann, Georg ;
Kowalski, Christian ;
Kaczmarek, Ingo ;
Reichart, Bruno .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2007, 31 (03) :339-343
[5]  
GRADY D, 2003, NY TIMES 0312
[6]   Mortality and morbidity in pre-sensitized pediatric heart transplant recipients with a positive donor crossmatch utilizing peri-operative plasmapheresis and cytolytic therapy [J].
Holt, D. Byron ;
Lublin, Douglas M. ;
Phelan, Donna L. ;
Boslaugh, Sarah E. ;
Gandhi, Sanjiv K. ;
Huddleston, Charles B. ;
Saffitz, Jeffrey E. ;
Canter, Charles E. .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2007, 26 (09) :876-882
[7]   Incidence and Risk Factors for Mortality in Infants Awaiting Heart Transplantation in the USA [J].
Mah, Douglas ;
Singh, Tajinder P. ;
Thiagarajan, Ravi R. ;
Gauvreau, Kimberlee ;
Piercey, Gary E. ;
Blume, Elizabeth D. ;
Fynn-Thompson, Francis ;
Almond, Christopher S. D. .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (12) :1292-1298
[8]  
McDiarmid S., 2007, SUMM ORG DON TRANSPL
[9]   Outcome of children with end-stage congenital heart disease waiting for cardiac transplantation [J].
Mital, S ;
Addonizio, LJ ;
Lamour, JM ;
Hsu, DT .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2003, 22 (02) :147-153
[10]  
Morrow WR, 1997, J HEART LUNG TRANSPL, V16, P1255